ProfessorsProfessors of Universidad Católica de Valencia San Vicente MàrtirFernando Revert Ros

Fernando Revert Ros

Universidad Católica de Valencia San Vicente Màrtir

H-index: 16

Europe-Spain

About Fernando Revert Ros

Fernando Revert Ros, With an exceptional h-index of 16 and a recent h-index of 9 (since 2020), a distinguished researcher at Universidad Católica de Valencia San Vicente Màrtir, specializes in the field of mitochondria, cancer, collagen, PNPT1, GPBP.

His recent articles reflect a diverse array of research interests and contributions to the field:

More Than Three Years for Normalisation of Routine Laboratory Values after Gluten Withdrawal in Paediatric Coeliac Patients

SP1 and NFY Regulate the Expression of PNPT1, a Gene Encoding a Mitochondrial Protein Involved in Cancer

Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein

GPBP inhibition using Q2 peptidomimetics

Fernando Revert Ros Information

University	Universidad Católica de Valencia San Vicente Màrtir
Position	CIPF & FS &
Citations(all)	1011
Citations(since 2020)	226
Cited By	884
hIndex(all)	16
hIndex(since 2020)	9
i10Index(all)	19
i10Index(since 2020)	8
Email	Access Email
University Profile Page	Universidad Católica de Valencia San Vicente Màrtir
Google Scholar	View Google Scholar Profile

Fernando Revert Ros Skills & Research Interests

mitochondria

cancer

collagen

PNPT1

GPBP

Top articles of Fernando Revert Ros

Title	Journal	Author(s)	Publication Date
More Than Three Years for Normalisation of Routine Laboratory Values after Gluten Withdrawal in Paediatric Coeliac Patients	Children	Ignacio Ventura Belén Rodriguez Sandra Suescum Fernando Revert Francisco Revert-Ros ...	2023/9/21
SP1 and NFY Regulate the Expression of PNPT1, a Gene Encoding a Mitochondrial Protein Involved in Cancer	International Journal of Molecular Sciences	Ignacio Ventura Fernando Revert Francisco Revert-Ros Lucía Gómez-Tatay Jesús A Prieto-Ruiz ...	2022/9/27
Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein			2020/4/28
GPBP inhibition using Q2 peptidomimetics			2020/1/28